Hydroxychloroquine (HCQ) — the controversial COVID-19 treatment touted by President Donald Trump — might be gaining new traction in the fight against the Wuhan coronavirus.
The latest positive results come from Vadodara, India, where city officials have conducted a major study involving more than 300,000 people, including “health workers and other frontline staff.”
The Indian Express reports:
The administration has analysed a sample of over 1 lakh [lakh = 100,000] residents, who were mostly close contacts of positive persons and the effect of HCQ in containing the transmission of the virus. According to the analysis, of the 48,873 close contacts of positive patients who took one dose of HCQ, 102 turned Covid-19 positive and 12 succumbed to the infection whereas 48 of the 17,776 close contacts of positive patients who took two doses of HCQ turned positive and only one died. The study also states that of the 33,563 close contacts of patients who took three HCQ doses, 43 tested positive and one died.
Local health official Dr. Devesh Patel told the paper, “It has shown positive results. We have the numbers and not one person has complained of complications. The only side effect reported is mild gastritis, which is common with administering heavy medicines and can be effectively handled.”
In other words, anyone who has taken the much more common azithromycin antibiotic for a simple sinus infection has probably suffered about the same distress — all gastric — as a subject of the Vadodara study. – READ MORE
Listen to the insightful Thomas Paine Podcast Below --